EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Development of a human herpesvirus 8-negative effusion-based lymphoma during treatment with dasatinib for chronic myeloid leukemia

Takahiro Suyama, Masao Hagihara, Naruaki Matsui, Rie Irie, Yoshiyuki Osamura, Tetsuo Sakai, Shouichi Watanabe, Shintarou Umemoto, Naoki Miyao

Journal of Clinical and Experimental Hematopathology · 2023

DOI: 10.3960/jslrt.22041 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2023. Verfasst von Takahiro Suyama und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Nippon Koukan Hospital, Kanagawa, Japan. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Pleural Effusion, Lymphoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 8, HumanLeukemia, Myelogenous, Chronic, BCR-ABL PositivePleural EffusionLymphomaMaleHumansAged, 80 and overDasatinibProtein Kinase Inhibitors

Stichwörter der Autor:innen

CD57 positive T cellHHV8-negative effusion-based lymphomaanti-tumor immunitydasatinibpleural effusion

Substanzen

DasatinibProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, Nippon Koukan Hospital, Kanagawa, Japan.
  • Department of Hematology, Eiju General Hospital, Tokyo, Japan.
  • Department of Pathology, Nippon Koukan Hospital, Kanagawa, Japan.

Zitieren

APA

Suyama, T., Hagihara, M., Matsui, N., Irie, R., Osamura, Y., Sakai, T., Watanabe, S., Umemoto, S., & Miyao, N. (2023). Development of a human herpesvirus 8-negative effusion-based lymphoma during treatment with dasatinib for chronic myeloid leukemia. Journal of Clinical and Experimental Hematopathology. https://doi.org/10.3960/jslrt.22041

Vancouver

Suyama T, Hagihara M, Matsui N, Irie R, Osamura Y, Sakai T, et al. Development of a human herpesvirus 8-negative effusion-based lymphoma during treatment with dasatinib for chronic myeloid leukemia. Journal of Clinical and Experimental Hematopathology. 2023. doi:10.3960/jslrt.22041

BibTeX
@article{Suyama2023,
  author = {Suyama, Takahiro and Hagihara, Masao and Matsui, Naruaki and Irie, Rie and Osamura, Yoshiyuki and Sakai, Tetsuo and Watanabe, Shouichi and Umemoto, Shintarou and Miyao, Naoki},
  title = {Development of a human herpesvirus 8-negative effusion-based lymphoma during treatment with dasatinib for chronic myeloid leukemia},
  journal = {Journal of Clinical and Experimental Hematopathology},
  year = {2023},
  doi = {10.3960/jslrt.22041}
}
Kostenlos starten →